Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederstatnews.com
STAT
Get the latest updates from STAT directly as they happen.
Follow now 233 followers
Latest posts
Last updated 13 minutes ago
Predicting biotech clinical trials & a new Alzheimer’s drug controversy
14 minutes ago
On this week’s episode of “The Readout LOUD”: The Kalshi prediction markets...
STAT+: GOP blocks effort to end Medicare test of AI prior authorization
about 1 hour ago
WASHINGTON — A Senate vote to halt a Medicare pilot that uses...
STAT+: Despite earnings celebration, UnitedHealth signals more financial pain for employers
about 3 hours ago
UnitedHealth Group smashed through investors’ earnings expectations in the second quarter, with...
Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts
about 3 hours ago
Medical experts are divided on Defense Secretary Pete Hegseth’s announcement that U.S...
WHO: Uganda is silent on updates following disclosure of Marburg outbreak
about 4 hours ago
The government of Uganda has gone quiet on an outbreak of the...
STAT+: Brain implant restores the sensation of touch in a person with quadriplegia
about 5 hours ago
Keith Thomas just wanted to pet his dog. A diving accident in...
STAT+: Medicare wants to shake up how it pays for clinical AI
about 6 hours ago
You’re reading the web edition of STAT’s Health Tech newsletter, our guide...
STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more
about 7 hours ago
Top of the morning to you, and a fine one it is...
STAT+: FDA approves Merck’s oral PCSK9 drug, a first
about 7 hours ago
Want to stay on top of the science and politics driving biotech...
STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
about 8 hours ago
Prediction markets have permeated the worlds of sports, politics, and reality television...
STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
about 9 hours ago
Eli Lilly is acquiring AtaiBeckley, the developer of psychedelic treatments for mental...
STAT+: Spring forward forever? Another daylight saving debate arrives in Congress
about 9 hours ago
Get your daily dose of health and medicine every weekday with STAT’s...